PetMed Express (PETS)
(Delayed Data from NSDQ)
$4.70 USD
-0.37 (-7.30%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $4.80 +0.10 (2.13%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.70 USD
-0.37 (-7.30%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $4.80 +0.10 (2.13%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Zacks News
Here's Why PetMed (PETS) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PetMed (PETS) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of 283.33% and 9.77%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Beat the Market the Zacks Way: Bank of New York Mellon, PetMed, Ulta Beauty in Focus
by Santanu Roy
Our time-tested methodologies helped investors navigate the market well last week. Here are some of our key performance data from the past three months.
EBAY Q3 Earnings and Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
EBAY's third-quarter 2024 results reflect a year-over-year increase in revenues and earnings, driven by Focus Categories and geo-specific investments.
4 Retail Stocks to Buy as Further Rate Cuts Loom
by Abhinab Dasgupta
Casey's, PetMed, Alibaba and Deckers Outdoor are four retail stocks that should do well in the coming months as the Fed finally initiates rate cuts.
Here's Why PetMed (PETS) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fiverr International (FVRR) Matches Q1 Earnings Estimates
by Zacks Equity Research
Fiverr (FVRR) delivered earnings and revenue surprises of 0% and 1.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
1stdibs.com (DIBS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of 11.11% and 3.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
MercadoLibre (MELI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
MercadoLibre (MELI) delivered earnings and revenue surprises of 2.11% and 9.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Reports Break-Even Earnings for Q2
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -100% and 7.95%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
PetMeds (PETS) to Advance Pet Care With New Collaboration
by Zacks Equity Research
PetMeds (PETS) is positioning itself more firmly in the field of pet health and wellness as a result of its established reputation in the pet pharmaceutical industry.
PetMed (PETS) Reports Break-Even Earnings for Q1
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -100% and 1.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for PetMed Express (PETS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to PetMed Express (PETS) stock based on the movements in the options market lately.
Time for Pet ETF on Upbeat Earnings from Chewy? (Revised)
by Sanghamitra Saha
The recent impressive earnings report from Chewy, the online pet-products retailer, may ignite investor optimism in the segment and its pure-play ETF PETS.
PetMed (PETS) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -73.33% and 10.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Fiverr International (FVRR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Fiverr (FVRR) delivered earnings and revenue surprises of 50% and 0.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
1stdibs.com (DIBS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
1stdibs (DIBS) delivered earnings and revenue surprises of 12.50% and 2.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
BigCommerce (BIGC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
BigCommerce (BIGC) delivered earnings and revenue surprises of 46.15% and 0.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PetMed (PETS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -90.48% and 7.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amazon (AMZN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Amazon (AMZN) delivered earnings and revenue surprises of 40% and 2.64%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ETFs & Stocks to Win Despite a Soft December Retail Sales
by Sanghamitra Saha
Retail sales in the United States fell 1.1% sequentially in December 2022. Year-over-year, retail sales grew 9.2%.
PetMed (PETS) Misses Q2 Earnings Estimates
by Zacks Equity Research
PetMed (PETS) delivered earnings and revenue surprises of -51.85% and 0.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
November Retail Sales Steady: 3 ETF & Stock Picks
by Sanghamitra Saha
3 ETF and stocks to play the surge in retail sales in November.
Earnings Preview: Amazon (AMZN) Q3 Earnings Expected to Decline
by Zacks Equity Research
Amazon (AMZN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.